Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, January 23 2017 7:26am ET - U.S. Markets open in 2 hours and 4 minutes.
Industry Center - Medical Laboratories & Research
Industry Center > Medical Laboratories & Research > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Health Care Plans
· Home Health Care
· Long-Term Care Facilities
· Medical Appliances & Equipment
· Medical Instruments & Supplies
· Medical Practitioners
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Medical Laboratories & Research News
Latest News
Saturday, Jan 21, 2017
·John Rogers Comments on Thermo Fisher Scientific Inc.
- Fri Jan 20
·John Rogers Comments on Charles River Laboratories Intl
- Fri Jan 20
·Baron Funds Comments on Novadaq Technologies
- Fri Jan 20
·Baron Funds Comments on Foundation Medicine
- Fri Jan 20
Friday, Jan 20, 2017
·CytoSorbents Launches VetResQ™ for U.S. Veterinary Market
PR Newswire - Fri Jan 20
·Great Basin Announces Request to Withdraw S-1 Registration Statement and Amendment to $75 Million 2016 Convertible Note
GlobeNewswire - Fri Jan 20
·CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
GlobeNewswire - Fri Jan 20
·Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference Call
Business Wire - Thu Jan 19
Thursday, Jan 19, 2017
·PAREXEL International Announces Date of Second Quarter Fiscal Year 2017 Earnings Release and Conference Call
Business Wire - Thu Jan 19
·[$$] Abbott Set for 12% EPS Growth
at - Thu Jan 19
·Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells
PR Newswire - Thu Jan 19
·Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results
GlobeNewswire - Thu Jan 19
·Abaxis To Report Third Quarter Fiscal Year 2017 Financial Results On Thursday, January 26, 2017
PR Newswire - Thu Jan 19
·Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017
Marketwire - Wed Jan 18
Wednesday, Jan 18, 2017
·SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Rad Laboratories, Inc. - BIO
PR Newswire - Wed Jan 18
·Agilent Technologies Extends Collaboration on Reproductive Genetics
Business Wire - Wed Jan 18
·Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy
PR Newswire - Wed Jan 18
·[$$] Bio-Rad to Acquire Former IPO Aspirant RainDance
at The Wall Street Journal Online - Tue Jan 17
·Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau
PR Newswire - Tue Jan 17
Tuesday, Jan 17, 2017
·Faruqi & Faruqi, LLP is Investigating Alere Inc. (ALR) on Behalf of its Shareholders
PR Newswire - Tue Jan 17
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Medical Laboratories & Research Headlines
More Finance RSS Feeds

Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?